Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ bone regeneration, addressing both translational and ethical concerns regarding animal models. In this study, we attempted to develop such a model to study material-driven regeneration, using a tissue engineering approach. By co-culturing human umbilical vein endothelial cells (HUVECs) with human bone marrow-derived mesenchymal stromal cells (hBMSCs) on silk fibroin scaffolds with in vitro critically sized defects, the growth of vascular-like networks and three-dimensional bone-like tissue was facilitated. After a model build-up phase of 28 days, materials were artificially implanted and HUVEC and hBMSC migration, cell-material interactions,...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Porous biodegradable silk scaffolds and human bone marrow derived mesenchymal stem cells (hMSCs) wer...
<div><p>The development of technologies to promote vascularization of engineered tissue would drive ...
Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ...
Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ...
Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ...
Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ...
Tissue engineering provides unique opportunities for regenerating diseased or damaged tissues using ...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Tissue engineering provides unique opportunities for regenerating diseased or damaged tissues using ...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Skeletal tissue has a good ability to self-regenerate after injury through the processes of bone hea...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Porous biodegradable silk scaffolds and human bone marrow derived mesenchymal stem cells (hMSCs) wer...
<div><p>The development of technologies to promote vascularization of engineered tissue would drive ...
Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ...
Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ...
Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ...
Advanced in vitro human bone defect models can contribute to the evaluation of materials for in situ...
Tissue engineering provides unique opportunities for regenerating diseased or damaged tissues using ...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Tissue engineering provides unique opportunities for regenerating diseased or damaged tissues using ...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Skeletal tissue has a good ability to self-regenerate after injury through the processes of bone hea...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Implant design for bone regeneration is expected to be optimized when implant structures resemble th...
Porous biodegradable silk scaffolds and human bone marrow derived mesenchymal stem cells (hMSCs) wer...
<div><p>The development of technologies to promote vascularization of engineered tissue would drive ...